Treatment

Paxalisib clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
5G-PEARL: Paxalisib in Malignant Brain Tumours
This study, 5G-PEARL, looks at combining two drugs, paxalisib and temozolomide, for people with aggressive brain tumours. It aims to see if this combination is safe and helps shrink tumours. This research could lead to better treatments for these types of cancer.
For: Malignant Primary Gliomas · Glioblastoma Multiforme (GBM)
United Kingdom